Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
NeuroBo Pharmaceuticals, Inc. (GEMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/29/2022 |
SC 13D/A
| DONG-A ST CO., LTD reports a 65.5% stake in NeuroBo Pharmaceuticals, Inc. |
| 11/10/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/23/2022 |
SC 13D/A
| JK BioPharma Solutions, Inc reports a 0% stake in NEUROBO PHARMACEUTICALS, INC. |
| 09/16/2022 |
SC 13D/A
| DONG-A ST CO., LTD reports a 10.7% stake in NeuroBo Pharmaceuticals, Inc. |
| 08/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/10/2021 |
SC 13D/A
| JK BioPharma Solutions, Inc reports a 9.8% stake in NEUROBO PHARMACEUTICALS, INC. |
| 09/01/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/30/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/27/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/15/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/16/2020 |
SC 13D/A
| NEUROBO PHARMACEUTICALS, INC. reports a 0% stake in NeuroBo Pharmaceuticals, Inc. |
| 01/10/2020 |
SC 13D/A
| Bisgaier Charles PhD reports a 0.4% stake in NeuroBo Pharmaceuticals, Inc. |
|
|